Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05429892 · ClinicalTrials.gov registry record · NA
FRESH Delivers: An Innovative Approach to Reducing Tobacco Use Among Rural Smokers
A NA study of Tobacco Dependence and Tobacco Cessation, sponsored by University of Arkansas.
- Recruiting
- Registry status
- NA
- Development phase
- 540
- Enrollment target
- 1
- Study location
NCT05429892: Recruiting NA study of Tobacco Dependence and Tobacco Cessation, sponsored by University of Arkansas.
NCT05429892 is a NA study of Tobacco Dependence and Tobacco Cessation that is actively recruiting participants, run by University of Arkansas. The registered enrollment target is 540 participants, above the 459-participant average among 28 other Tobacco Dependence trials with a reported enrollment target (18% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05429892, a NA study of Tobacco Dependence and Tobacco Cessation, is actively recruiting participants, sponsored by University of Arkansas.
- RECRUITING
- Registry status
- NA
- Development phase
- 540 participants
- Enrollment target
- 1
- Study location
Study Summary
The long-term goal of FRESH Delivers is to fill a critical gap in knowledge on the role of a home-based food delivery social intervention in the elimination of tobacco-caused cancer health burdens. The central hypothesis is that smokers who receive real-time video-based motivational counseling and home-based food deliveries will have greater cotinine-verified 7-day point prevalence abstinence than those who receive real-time video-based motivational counseling alone or home food delivery alone. The rationale for this approach is that studies show increased odds of smoking cessation with increasing food security.
Primary Outcome
The study is powered to examine changes in our primary outcome, cotinine-verified 7-day point prevalence abstinence using survey data and collecting a saliva sample.
Conditions Studied
Interventions
- BEHAVIORAL Smoking cessation counseling and food delivery
- BEHAVIORAL Smoking cessation counseling
- BEHAVIORAL Food delivery
Study Locations (1)
Arkansas
- University of Arkansas for Medical Sciences - Little Rock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 540 participants |
| Start Date | 2023-08-09 |
| Est. Completion | 2026-09-30 |
| Phase | NA |
What NCT05429892 shows while recruiting
NCT05429892 is an interventional study that assigns participants to a tested intervention. The registered 540 participants enrollment target is mid-sized for trials with a published cap, above the 459-participant average among 28 other Tobacco Dependence trials with a reported enrollment target (18% higher).
The record links to 3 conditions, with Tobacco Dependence appearing as the primary indexed condition, and to 3 interventions - of which Smoking cessation counseling and food delivery is the first listed.
NCT05429892 reports a single indexed study location in Arkansas.
Frequently Asked Questions
What is clinical trial NCT05429892 about?
NCT05429892 is a clinical study titled "FRESH Delivers: An Innovative Approach to Reducing Tobacco Use Among Rural Smokers". The long-term goal of FRESH Delivers is to fill a critical gap in knowledge on the role of a home-based food delivery social intervention in the elimination of tobacco-caused cancer health burdens. The central hypothesis is that smokers who receive real-time video-based motivational counseling and h...
What is the current status of trial NCT05429892?
This trial is currently recruiting. It is a NA study. The enrollment target is 540 participants. The study started on 2023-08-09. Estimated completion is 2026-09-30.
What conditions does trial NCT05429892 study?
This clinical trial studies the following conditions: Tobacco Dependence, Tobacco Cessation, Food Security.
What interventions are being tested in trial NCT05429892?
The interventions under investigation include: Smoking cessation counseling and food delivery (BEHAVIORAL), Smoking cessation counseling (BEHAVIORAL), Food delivery (BEHAVIORAL).
Who is sponsoring clinical trial NCT05429892?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05429892 being conducted?
This trial has 1 study location across Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tobacco Dependence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05429892's enrollment target sits among peer trials
540 7th of 28 higher than 22 of 28 other Tobacco Dependence trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Tobacco Dependence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Harm Reduction for Smokers With Mental Illness
RECRUITING · NA
-
Reach Through Equitable Implementation in Utah
RECRUITING · NA
-
Use of Nicotine Pouches Among Daily Smokers
RECRUITING · NA
-
Smoke-free Home Study in Subsidized Housing
RECRUITING · NA
-
Assessment of Biomarkers in Children to Help Parents Quit Tobacco
ACTIVE NOT RECRUITING · NA
-
Evaluation of Tobacco Treatment Strategies for Inpatient Psychiatry
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04557462 · 540 participants · Phase 3
A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
- NCT04956640 · 540 participants · Phase 1
Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)
- NCT05549297 · 540 participants · Phase 3
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
- NCT05588245 · 540 participants · NA
Trial of Community-based Patient Navigation
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI